CD274 and cancer: However, there may be a difference in sensitivity to PD-L1 between these two channels; a higher concentration of anti-PD-L1 blocking antibodies was necessary to unleash Kv1.3 activity in T cells from cancer patients compared to KCa3.1 [82].